Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10121 |
| Vaccine Name | KAMRAB-003 |
| Disease Name | Rabies |
| Disease Classification | Neurologic |
| Virus Name | Rabies virus |
| Nucleic Acid Content | negative-sense, single-stranded RNA |
| Vaccine Type | Live-attenuated |
| Vaccine Status | Approved |
| Manufacturer | Kamada Ltd. |
| Year of Manufacturing | 2014 |
| Manufacturing Country | USA |
| Age | 18 - 75 years |
| Dosage | 5 doses on day 0, 3, 7, 14 and 28 |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | NA |
| Description | NA |
| Approving Organisation | US FDA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT02040090 |
| Reference Link | https://clinicaltrials.gov/ct2/show/NCT02040090?cond=Rabies+Human&phase=23&draw=2&rank=5 |
| Additional Links | https://pdf.hres.ca/dpd_pm/00048173.PDF |